Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing

Current antiviral therapy fails to cure chronic hepatitis B virus (HBV) infection because of persistent covalently closed circular DNA (cccDNA). CRISPR/Cas9-mediated specific cleavage of cccDNA is a potentially curative strategy for chronic hepatitis B (CHB). However, the CRISPR/Cas system inevitabl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Ther Nucleic Acids
Main Authors: Yang, Yu-Chan, Chen, Yu-Hsiang, Kao, Jia-Horng, Ching, Chi, Liu, I-Jung, Wang, Chih-Chiang, Tsai, Cheng-Hsueh, Wu, Fang-Yi, Liu, Chun-Jen, Chen, Pei-Jer, Chen, Ding-Shinn, Yang, Hung-Chih
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Gene & Cell Therapy 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7150432/
https://ncbi.nlm.nih.gov/pubmed/32278307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtn.2020.03.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados